...2012, MonoSol Rx said it acquired U.S. Patent No. 8,241,661 from inventors Richard and Joseph Fuisz...

...investigating the use of a medicated tampon to deliver the NSAID keterolac to treat dysmenorrhea. Fuisz...
...majority stake in Femina. Financial terms were not disclosed. Femina Pharma Inc. , Miami, Fla. Fuisz...

...forms. Fuisz, said the IP will complement its anti-abuse technology. Further details were not disclosed. Fuisz...

...Analgesia Phase III Lambda Hyperphosphatemia Phase III Reminyl Alzheimer's disease NDA, Mkt. in Europe 1999 Fuisz...

...as EVP of sales, marketing and business development, formerly president of the pharmaceutical division of Fuisz Technologies Ltd. WIR...

...Richard Fuisz announced the formation of UniPharm to develop a quick dissolve solid dosage delivery technology...
...to develop a quick dissolve solid dosage delivery technology platform. Fuisz founded drug delivery company Fuisz Technologies Ltd....

...million. BVF acquired Clonmel, also a generics manufacturer and marketer, through its 1999 purchase of Fuisz...

...$535.0 MedImmune U.S. Bioscience $492.0 Baxter North American Vaccine $390.0 Becton Dickinson Clontech $200.0 Biovail Fuisz...

...its intention to merge with Roberts Pharmaceutical Corp. and latterly acquired selected European operations of Fuisz Technologies Ltd....

...$91 million of debt (see BioCentury, Aug. 2). Biovail Corp. International (BVF; TSE:BVF), Toronto, Ontario Fuisz Technologies Ltd....